870064-73-6

Basic information

• Product Name: 6-CHLORO-8-NITRO-4H-BENZO[1,4]OXAZIN-3-ONE
• Synonyms: 6-CHLORO-8-NITRO-4H-BENZO[1,4]OXAZIN-3-ONE
• CAS NO: 870064-73-6
• Molecular Formula: C₈H₅ClN₂O₄
• Molecular Weight: 228.5893
• Mol File: 870064-73-6.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-CHLORO-8-NITRO-4H-BENZO[1,4]OXAZIN-3-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-8-NITRO-4H-BENZO[1,4]OXAZIN-3-ONE(870064-73-6)
• EPA Substance Registry System: 6-CHLORO-8-NITRO-4H-BENZO[1,4]OXAZIN-3-ONE(870064-73-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 870064-73-6(Hazardous Substances Data)

Usage

Molecular weight

203.58 g/mol

Physical state

Bright yellow solid

Functional groups

Chlorine and nitro

Uses

Building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds

Potential applications

Materials science and organic synthesis

Cautions

Hazardous if not properly handled or disposed of

Upstream product

• 6358-08-3 4-chloro-6-nitro-2-aminophenol 
• 105-36-2 ethyl bromoacetate 
• 88-87-9 4-chloro-2,6-dinitrophenol 
• 1276684-06-0 ethyl 4-chloro-2,6-dinitrophenoxyacetate 
• 79-04-9 chloroacetyl chloride 
• 96-35-5 glycolic acid methyl ester 
• 95-85-2 2-hydroxy-5-chloro-aniline 
• 35588-38-6 2-chloro-N-(5-chloro-2-hydroxyphenyl)acetamide 
• 908863-01-4 2-chloro-N-(5-chloro-2-hydroxy-3-nitro-phenyl)-acetamide 

Downstream Products

• 1313588-10-1 C₂₂H₁₈Cl₂F₃N₅O₄ 
• 1338064-83-7 1-(4-(trifluoromethyl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-84-8 1-(2-(dimethylamino)-4-(trifluoromethyl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-85-9 1-(4-(trifluoromethyl)-2-(pyrrolidin-1-yl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b] [1,4]oxazin-8-yl)urea 
• 1338064-86-0 1-(4-(trifluoromethyl)-2-(piperidin-1-yl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-87-1 1-(4-chlorobenzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-88-2 1-(4-chloro-2-(dimethylamino)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-89-3 1-(4-chloro-2-(pyrrolidin-1-yl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-91-7 1-(4-chloro-2-(piperidin-1-yl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338064-92-8 1-(4-methyl-2-(piperidin-1-yl)benzyl)-3-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-8-yl)urea 
• 1338065-32-9 1-[[2-(2-dimethylaminoethoxy)-4-(trifluoromethyl)phenyl]methyl]-3-(3-oxo-4H-1,4-benzoxazin-8-yl)urea 
• 1338065-30-7 1-[(4-methyl-2-pyrrolidin-1-yl-phenyl)methyl]-3-(3-oxo-4H-1,4-benzoxazin-8-yl)urea 
• 1338065-29-4 1-[(4-tert-butylphenyl)methyl]-3-(3-oxo-4H-1,4-benzoxazin-8-yl)urea 
• 1338065-28-3 1-[[2-(imidazol-1-yl)-4-(trifluoromethyl)phenyl]methyl]-3-(3-oxo-4H-1,4-benzoxazin-8-yl)urea 

Relevant articles and documents

Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1)

Transient receptor potential vanilloid 1 (TRPV1) has emerged as a promising therapeutic target. While radiolabeled resiniferatoxin (RTX) has provided a powerful tool for characterization of vanilloid binding to TRPV1, TRPV1 shows 20-fold weaker binding to

"TRPV1 VANILLOID RECEPTOR ANTAGONISTS WITH A BICYCLIC PORTION"

The invention discloses compounds of formula I wherein Y is a group of formula A, B, C, D, or E: and W, Q, n, R1, R2, R3, U1-U5, J and K have the meanings given in the description. The compounds of formula I are TRPV1 antagonists and are useful as active

Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors

Previous efforts have led to the identification of a potent, selective, and nonphlorizin based SGLT2 inhibitor 1. This Letter describes efforts to further optimize the potency, microsomal stability, solubility and pharmacokinetic properties of this series of SGLT2 inhibitors. From these efforts, compounds 28 and 32 have improved solubility and pharmacokinetic properties compared to compound 1.